The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00105-013-2594-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!